[Prevention of HIV infections (AIDS) in ENT practice and the clinic] NLM AIDSLINE Important note: Information in this article was accurate in 1988. The state of the art may have changed since the publication date.

Click here to return to AIDSLINE main menu
DonateNow
Print this Article


[Prevention of HIV infections (AIDS) in ENT practice and the clinic]

Laryngol Rhinol Otol (Stuttg). 1987 Oct;66(10):513-4. Unique Identifier : AIDSLINE MED/88093382
Wilmes E; Gurtler L; Klinik und Poliklinik fur HNO-Kranke der Universitat Munchen.

Abstract: In comparison to sexual contact the transmitted droplet infection or the mucosa contact are of minor relevance for HIV, the causative agent of acquired immune deficiency (AIDS). These channels of infections should nevertheless not be disregarded. Due to his activity, connected with a very close contact with exudations of a wound, blood, saliva and mucosae, the ENT-specialist increased hazard of infection by the HIV virus. Since 80% of the infected persons are able to discharge viruses free from symptoms for years, the ENT specialist should be informed about the pattern of distribution of this infectious disease as well as about suitable methods of prevention. Recommendations to practice and clinic for the prevention of transmitting HIV infections are given.
Keywords: Acquired Immunodeficiency Syndrome/*PREVENTION & CONTROL/ TRANSMISSION English Abstract Human Occupational Diseases/*PREVENTION & CONTROL/TRANSMISSION *Otolaryngology Otorhinolaryngologic Diseases/THERAPY Risk Factors JOURNAL ARTICLE

KWDacquiredimmunodeficiencysyndrome/KWDprevention&control/transmissionenglishabstracthumanoccupationaldiseases/KWDprevention&control/transmissionKWDotolaryngologyotorhinolaryngologicdiseases/therapyriskfactorsjournalarticle
880430
M8840404

Copyright © 1988 - National Library of Medicine. Reproduced under license with the National Library of Medicine, Bethesda, MD.

AEGiS is a 501(c)3, not-for-profit, tax-exempt, educational corporation. AEGiS is made possible through unrestricted funding from Boehringer Ingelheim, Bridgestone/Firestone Charitable Trust, Bristol-Myers Squibb Company, Elton John AIDS Foundation, Gill Foundation, the National Library of Medicine, Quest Diagnostics, Roche and Trimeris, and donations from users like you. Always watch for outdated information. This article first appeared in 1988. This material is designed to support, not replace, the relationship that exists between you and your doctor.

AEGiS presents published material, reprinted with permission and neither endorses nor opposes any material. All information contained on this website, including information relating to health conditions, products, and treatments, is for informational purposes only. It is often presented in summary or aggregate form. It is not meant to be a substitute for the advice provided by your own physician or other medical professionals. Always discuss treatment options with a doctor who specializes in treating HIV.

Copyright ©1980, 1988. AEGiS. All materials appearing on AEGiS are protected by copyright as a collective work or compilation under U.S. copyright and other laws and are the property of AEGiS, or the party credited as the provider of the content. .